English

METABASIS THERAPEUTICS INC

EDGAR

Quarterly report (10-Q) · filed 2009-11-12

25 filing records in this dataset, filed from 2004-08-16 to 2009-11-12. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

4.88 million USD

2009-09-30 · USD

Exact inputs and evidence

Revenue: 4883000 USD Source

Operating margin

54.56%

2009-09-30 · %

Exact inputs and evidence

Operating Income: 2664000 USD Source
Revenue: 4883000 USD Source

Operating cash flow

-2.91 million USD

2009-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -9332000 USD Source
Operating Cash Flow: -6424000 USD Source

Free cash flow

-2.91 million USD

2009-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -9332000 USD Source
Operating Cash Flow: -6424000 USD Source
Capital Expenditure: 0 USD Source
Capital Expenditure: 0 USD Source

Cash and cash equivalents: 2.22 million USD 2009-09-30 Source
Exact value

2215000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

18.3 million USD

2008-10-01 – 2009-09-30

Exact inputs and evidence

Revenue: 4810000 USD · 2008-01-01 – 2008-12-31 Source
Revenue: 3031000 USD · 2008-01-01 – 2008-09-30 Source
Revenue: 1889000 USD · 2009-01-01 – 2009-03-31 Source
Revenue: 9712000 USD · 2009-04-01 – 2009-06-30 Source
Revenue: 4883000 USD · 2009-07-01 – 2009-09-30 Source

Net income

-12.4 million USD

2008-10-01 – 2009-09-30

Exact inputs and evidence

Net income: -42314000 USD · 2008-01-01 – 2008-12-31 Source
Net income: -32476000 USD · 2008-01-01 – 2008-09-30 Source
Net income: -8241000 USD · 2009-01-01 – 2009-03-31 Source
Net income: 3060000 USD · 2009-04-01 – 2009-06-30 Source
Net income: 2662000 USD · 2009-07-01 – 2009-09-30 Source

Operating cash flow

-19.8 million USD

2008-10-01 – 2009-09-30

Exact inputs and evidence

Operating cash flow: -33073000 USD · 2008-01-01 – 2008-12-31 Source
Operating cash flow: -22602000 USD · 2008-01-01 – 2008-09-30 Source
Operating cash flow: -8868000 USD · 2009-01-01 – 2009-03-31 Source
Operating cash flow: -6424000 USD · 2009-01-01 – 2009-06-30 Source
Operating cash flow: -8868000 USD · 2009-01-01 – 2009-03-31 Source
Operating cash flow: -9332000 USD · 2009-01-01 – 2009-09-30 Source
Operating cash flow: -6424000 USD · 2009-01-01 – 2009-06-30 Source

Capital expenditure

9 thousand USD

2008-10-01 – 2009-09-30

Exact inputs and evidence

Capital expenditure: 525000 USD · 2008-01-01 – 2008-12-31 Source
Capital expenditure: 516000 USD · 2008-01-01 – 2008-09-30 Source
Capital expenditure: 0 USD · 2009-01-01 – 2009-03-31 Source
Capital expenditure: 0 USD · 2009-01-01 – 2009-06-30 Source
Capital expenditure: 0 USD · 2009-01-01 – 2009-03-31 Source
Capital expenditure: 0 USD · 2009-01-01 – 2009-09-30 Source
Capital expenditure: 0 USD · 2009-01-01 – 2009-06-30 Source

Free cash flow

-19.8 million USD

2008-10-01 – 2009-09-30

Exact inputs and evidence

Operating cash flow: -33073000 USD · 2008-01-01 – 2008-12-31 Source
Operating cash flow: -22602000 USD · 2008-01-01 – 2008-09-30 Source
Operating cash flow: -8868000 USD · 2009-01-01 – 2009-03-31 Source
Operating cash flow: -6424000 USD · 2009-01-01 – 2009-06-30 Source
Operating cash flow: -8868000 USD · 2009-01-01 – 2009-03-31 Source
Operating cash flow: -9332000 USD · 2009-01-01 – 2009-09-30 Source
Operating cash flow: -6424000 USD · 2009-01-01 – 2009-06-30 Source
Capital expenditure: 525000 USD · 2008-01-01 – 2008-12-31 Source
Capital expenditure: 516000 USD · 2008-01-01 – 2008-09-30 Source
Capital expenditure: 0 USD · 2009-01-01 – 2009-03-31 Source
Capital expenditure: 0 USD · 2009-01-01 – 2009-06-30 Source
Capital expenditure: 0 USD · 2009-01-01 – 2009-03-31 Source
Capital expenditure: 0 USD · 2009-01-01 – 2009-09-30 Source
Capital expenditure: 0 USD · 2009-01-01 – 2009-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2009-11-12.

Financial data available through: 2008-12-31.

Coverage by financial measure

Revenue: 7 of 11 periods available· newest 2008-12-31
Operating income: 7 of 11 periods available· newest 2008-12-31
Net income: 7 of 11 periods available· newest 2008-12-31
Operating cash flow: 7 of 11 periods available· newest 2008-12-31
Capital expenditure: 7 of 11 periods available· newest 2008-12-31
Total assets: 6 of 11 periods available· newest 2008-12-31
Total liabilities: 4 of 11 periods available· newest 2008-12-31
Current assets: 6 of 11 periods available· newest 2008-12-31
Current liabilities: 6 of 11 periods available· newest 2008-12-31
Cash and cash equivalents: 7 of 11 periods available· newest 2008-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-46.7%

Prior period

USD 9.02 million

2007-01-01 – 2007-12-31
Current period

USD 4.81 million

2008-01-01 – 2008-12-31

Exact inputs and evidence

4810000 − 9019000 = -4209000 USD

9019000 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
4810000 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · METABASIS THERAPEUTICS INC · 2008-12-31 METABASIS THERAPEUTICS INC (edgar:1053221) Year-over-year change in Revenue: -4209000 USD Concept: fundies:Revenue Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T14:04:06Z Snapshot: 1d6c83a218ae99f29dc50d398c406edd10c3eadb1779cb3c6dd71ffe2d8d9366 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053221?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 4810000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001193125-09-069381.txt#6394 Input fundies:Revenue: 9019000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001193125-09-069381.txt#6394
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 515,000

Prior period

−USD 41.8 million

2007-01-01 – 2007-12-31
Current period

−USD 42.31 million

2008-01-01 – 2008-12-31

Exact inputs and evidence

-42314000 − -41799000 = -515000 USD

-41799000 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
-42314000 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · METABASIS THERAPEUTICS INC · 2008-12-31 METABASIS THERAPEUTICS INC (edgar:1053221) Year-over-year change in Net income: -515000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T14:04:06Z Snapshot: 1d6c83a218ae99f29dc50d398c406edd10c3eadb1779cb3c6dd71ffe2d8d9366 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053221?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -42314000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001193125-09-069381.txt#7727 Input fundies:NetIncome: -41799000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001193125-09-069381.txt#7727
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 3.31 million

Prior period

−USD 36.38 million

2007-01-01 – 2007-12-31
Current period

−USD 33.07 million

2008-01-01 – 2008-12-31

Exact inputs and evidence

-33073000 − -36383000 = 3310000 USD

-36383000 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
-33073000 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · METABASIS THERAPEUTICS INC · 2008-12-31 METABASIS THERAPEUTICS INC (edgar:1053221) Year-over-year change in Operating cash flow: 3310000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T14:04:06Z Snapshot: 1d6c83a218ae99f29dc50d398c406edd10c3eadb1779cb3c6dd71ffe2d8d9366 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053221?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -33073000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001193125-09-069381.txt#7923 Input fundies:OperatingCashFlow: -36383000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001193125-09-069381.txt#7923
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-76.9%

Prior period

USD 2.27 million

2007-01-01 – 2007-12-31
Current period

USD 525,000

2008-01-01 – 2008-12-31

Exact inputs and evidence

525000 − 2274000 = -1749000 USD

2274000 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
525000 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · METABASIS THERAPEUTICS INC · 2008-12-31 METABASIS THERAPEUTICS INC (edgar:1053221) Year-over-year change in Capital expenditure: -1749000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T14:04:06Z Snapshot: 1d6c83a218ae99f29dc50d398c406edd10c3eadb1779cb3c6dd71ffe2d8d9366 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053221?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 525000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001193125-09-069381.txt#7984 Input fundies:CapitalExpenditure: 2274000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001193125-09-069381.txt#7984
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2008 2008-01-01 – 2008-12-31

Revenue USD 4.81 million 100% of revenue
Operating costs Derived USD 47.11 million 979% of revenue
Operating income −USD 42.3 million −879% of revenue
Tax, interest and other Derived USD 17,000 0.4% of revenue
Net income −USD 42.31 million −880% of revenue

Cash

Operating cash flow −USD 33.07 million −688% of revenue
Capital expenditure USD 525,000 11% of revenue
Free cash flow Derived −USD 33.6 million −699% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2002 Operating loss: operating costs were 666% of revenue.
2003 Operating loss: operating costs were 203% of revenue.
2004 Operating loss: operating costs were 323% of revenue.
2005 Operating loss: operating costs were 754% of revenue.
2006 Operating loss: operating costs were 939% of revenue.
2007 Operating loss: operating costs were 592% of revenue.
2008 Operating loss: operating costs were 979% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2002 2002-01-01 – 2002-12-31	2278000	15163000 Derived	-12885000	-88000 Derived	-12797000	-6475000 Derived	Source 2002-01-01 – 2002-12-31: 2278000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -12885000 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -12797000 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -5669000 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 806000 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	9124000	18507000 Derived	-9383000	46000 Derived	-9429000	-16627000 Derived	Source 2003-01-01 – 2003-12-31: 9124000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -9383000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -9429000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -15729000 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 898000 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	6837000	22112000 Derived	-15275000	-303000 Derived	-14972000	-13324000 Derived	Source 2004-01-01 – 2004-12-31: 6837000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -15275000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -14972000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -11998000 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 1326000 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	3771000	28438000 Derived	-24667000	-1087000 Derived	-23580000	-16733000 Derived	Source 2005-01-01 – 2005-12-31: 3771000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -24667000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -23580000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -13513000 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 3220000 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	4386000	41195000 Derived	-36809000	-3541000 Derived	-33268000	-30566000 Derived	Source 2006-01-01 – 2006-12-31: 4386000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -36809000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -33268000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -27336000 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 3230000 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	9019000	53357000 Derived	-44338000	-2539000 Derived	-41799000	-38657000 Derived	Source 2007-01-01 – 2007-12-31: 9019000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -44338000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -41799000 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -36383000 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 2274000 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	4810000	47107000 Derived	-42297000	17000 Derived	-42314000	-33598000 Derived	Source 2008-01-01 – 2008-12-31: 4810000 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -42297000 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -42314000 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -33073000 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 525000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 4.8M 2008

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-12-31	Revenue	2278000	Revenue: 2278000 Open source
20032003-12-31	Revenue	9124000	Revenue: 9124000 Open source
20042004-12-31	Revenue	6837000	Revenue: 6837000 Open source
20052005-12-31	Revenue	3771000	Revenue: 3771000 Open source
20062006-12-31	Revenue	4386000	Revenue: 4386000 Open source
20072007-12-31	Revenue	9019000	Revenue: 9019000 Open source
20082008-12-31	Revenue	4810000	Revenue: 4810000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-46.7% 2008

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20022002-12-31	Year over year	No prior comparable period	Revenue: 2278000 Open source
20032003-12-31	Year over year	300.5%	Revenue: 9124000 Open source Revenue: 2278000 Open source
20042004-12-31	Year over year	-25.1%	Revenue: 6837000 Open source Revenue: 9124000 Open source
20052005-12-31	Year over year	-44.8%	Revenue: 3771000 Open source Revenue: 6837000 Open source
20062006-12-31	Year over year	16.3%	Revenue: 4386000 Open source Revenue: 3771000 Open source
20072007-12-31	Year over year	105.6%	Revenue: 9019000 Open source Revenue: 4386000 Open source
20082008-12-31	Year over year	-46.7%	Revenue: 4810000 Open source Revenue: 9019000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -879.4% 2008

Net margin -879.7% 2008

Free cash flow margin -698.5% 2008

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20022002-12-31	Operating margin	-565.6%	Operating Income: -12885000 Open source Revenue: 2278000 Open source
20032003-12-31	Operating margin	-102.8%	Operating Income: -9383000 Open source Revenue: 9124000 Open source
20042004-12-31	Operating margin	-223.4%	Operating Income: -15275000 Open source Revenue: 6837000 Open source
20052005-12-31	Operating margin	-654.1%	Operating Income: -24667000 Open source Revenue: 3771000 Open source
20062006-12-31	Operating margin	-839.2%	Operating Income: -36809000 Open source Revenue: 4386000 Open source
20072007-12-31	Operating margin	-491.6%	Operating Income: -44338000 Open source Revenue: 9019000 Open source
20082008-12-31	Operating margin	-879.4%	Operating Income: -42297000 Open source Revenue: 4810000 Open source
20022002-12-31	Net margin	-561.8%	Net Income: -12797000 Open source Revenue: 2278000 Open source
20032003-12-31	Net margin	-103.3%	Net Income: -9429000 Open source Revenue: 9124000 Open source
20042004-12-31	Net margin	-219%	Net Income: -14972000 Open source Revenue: 6837000 Open source
20052005-12-31	Net margin	-625.3%	Net Income: -23580000 Open source Revenue: 3771000 Open source
20062006-12-31	Net margin	-758.5%	Net Income: -33268000 Open source Revenue: 4386000 Open source
20072007-12-31	Net margin	-463.5%	Net Income: -41799000 Open source Revenue: 9019000 Open source
20082008-12-31	Net margin	-879.7%	Net Income: -42314000 Open source Revenue: 4810000 Open source
20022002-12-31	Free cash flow margin	-284.2%	Revenue: 2278000 Open source Operating Cash Flow: -5669000 Open source Capital Expenditure: 806000 Open source
20032003-12-31	Free cash flow margin	-182.2%	Revenue: 9124000 Open source Operating Cash Flow: -15729000 Open source Capital Expenditure: 898000 Open source
20042004-12-31	Free cash flow margin	-194.9%	Revenue: 6837000 Open source Operating Cash Flow: -11998000 Open source Capital Expenditure: 1326000 Open source
20052005-12-31	Free cash flow margin	-443.7%	Revenue: 3771000 Open source Operating Cash Flow: -13513000 Open source Capital Expenditure: 3220000 Open source
20062006-12-31	Free cash flow margin	-696.9%	Revenue: 4386000 Open source Operating Cash Flow: -27336000 Open source Capital Expenditure: 3230000 Open source
20072007-12-31	Free cash flow margin	-428.6%	Revenue: 9019000 Open source Operating Cash Flow: -36383000 Open source Capital Expenditure: 2274000 Open source
20082008-12-31	Free cash flow margin	-698.5%	Revenue: 4810000 Open source Operating Cash Flow: -33073000 Open source Capital Expenditure: 525000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -33.1M 2008

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-12-31	Operating cash flow	-5669000	Operating Cash Flow: -5669000 Open source
20032003-12-31	Operating cash flow	-15729000	Operating Cash Flow: -15729000 Open source
20042004-12-31	Operating cash flow	-11998000	Operating Cash Flow: -11998000 Open source
20052005-12-31	Operating cash flow	-13513000	Operating Cash Flow: -13513000 Open source
20062006-12-31	Operating cash flow	-27336000	Operating Cash Flow: -27336000 Open source
20072007-12-31	Operating cash flow	-36383000	Operating Cash Flow: -36383000 Open source
20082008-12-31	Operating cash flow	-33073000	Operating Cash Flow: -33073000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -33.6M 2008

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-12-31	Free cash flow	-6475000	Operating Cash Flow: -5669000 Open source Capital Expenditure: 806000 Open source
20032003-12-31	Free cash flow	-16627000	Operating Cash Flow: -15729000 Open source Capital Expenditure: 898000 Open source
20042004-12-31	Free cash flow	-13324000	Operating Cash Flow: -11998000 Open source Capital Expenditure: 1326000 Open source
20052005-12-31	Free cash flow	-16733000	Operating Cash Flow: -13513000 Open source Capital Expenditure: 3220000 Open source
20062006-12-31	Free cash flow	-30566000	Operating Cash Flow: -27336000 Open source Capital Expenditure: 3230000 Open source
20072007-12-31	Free cash flow	-38657000	Operating Cash Flow: -36383000 Open source Capital Expenditure: 2274000 Open source
20082008-12-31	Free cash flow	-33598000	Operating Cash Flow: -33073000 Open source Capital Expenditure: 525000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

87.8% 2008

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2002-12-31	Liabilities / assets	Not reported	No source recorded
2003-12-31	Liabilities / assets	Not reported	Total Assets: 29110000 Open source
2004-12-31	Liabilities / assets	Not reported	Total Assets: 47860000 Open source
20052005-12-31	Liabilities / assets	19.4%	Total Liabilities: 14296000 Open source Total Assets: 73878000 Open source
20062006-12-31	Liabilities / assets	20.6%	Total Liabilities: 17717000 Open source Total Assets: 85855000 Open source
20072007-12-31	Liabilities / assets	36%	Total Liabilities: 18022000 Open source Total Assets: 50123000 Open source
20082008-12-31	Liabilities / assets	87.8%	Total Liabilities: 24361000 Open source Total Assets: 27742000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.63× 2008

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2002-12-31	Current assets / current liabilities	Not reported	No source recorded
20032003-12-31	Current assets / current liabilities	6.15×	Current Assets: 26680000 Open source Current Liabilities: 4338000 Open source
20042004-12-31	Current assets / current liabilities	9.89×	Current Assets: 45506000 Open source Current Liabilities: 4600000 Open source
20052005-12-31	Current assets / current liabilities	7.75×	Current Assets: 69062000 Open source Current Liabilities: 8916000 Open source
20062006-12-31	Current assets / current liabilities	7.54×	Current Assets: 79413000 Open source Current Liabilities: 10536000 Open source
20072007-12-31	Current assets / current liabilities	3.78×	Current Assets: 43595000 Open source Current Liabilities: 11527000 Open source
20082008-12-31	Current assets / current liabilities	1.63×	Current Assets: 22690000 Open source Current Liabilities: 13898000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2002 2002-01-01 – 2002-12-31	−USD 12.8 million Exact value Exact value: -12797000 USD 2002-01-01 – 2002-12-31: -12797000 USD Inspect Net Income Open source Share or cite Citation for Net Income · METABASIS THERAPEUTICS INC · 2002-12-31 METABASIS THERAPEUTICS INC (edgar:1053221) Net Income: -12797000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T14:04:06Z Snapshot: 1d6c83a218ae99f29dc50d398c406edd10c3eadb1779cb3c6dd71ffe2d8d9366 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053221/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -12797000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001047469-05-008544.txt#8152 The citation records this snapshot. The page link may show a newer release later.	−USD 5.67 million Exact value Exact value: -5669000 USD 2002-01-01 – 2002-12-31: -5669000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · METABASIS THERAPEUTICS INC · 2002-12-31 METABASIS THERAPEUTICS INC (edgar:1053221) Operating Cash Flow: -5669000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T14:04:06Z Snapshot: 1d6c83a218ae99f29dc50d398c406edd10c3eadb1779cb3c6dd71ffe2d8d9366 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053221/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5669000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001047469-05-008544.txt#8376 The citation records this snapshot. The page link may show a newer release later.	USD 806,000 Exact value Exact value: 806000 USD 2002-01-01 – 2002-12-31: 806000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · METABASIS THERAPEUTICS INC · 2002-12-31 METABASIS THERAPEUTICS INC (edgar:1053221) Capital Expenditure: 806000 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T14:04:06Z Snapshot: 1d6c83a218ae99f29dc50d398c406edd10c3eadb1779cb3c6dd71ffe2d8d9366 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053221/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 806000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001047469-05-008544.txt#8428 The citation records this snapshot. The page link may show a newer release later.	−USD 6.48 million Calculation and evidence -5669000 − 806000 USD Exact free cash flow: -6475000 USD 2002-01-01 – 2002-12-31: -5669000 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 806000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · METABASIS THERAPEUTICS INC · 2002-12-31 METABASIS THERAPEUTICS INC (edgar:1053221) Free cash flow: -6475000 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T14:04:06Z Snapshot: 1d6c83a218ae99f29dc50d398c406edd10c3eadb1779cb3c6dd71ffe2d8d9366 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053221?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5669000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001047469-05-008544.txt#8376 Input fundies:CapitalExpenditure: 806000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001047469-05-008544.txt#8428 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 9.43 million Exact value Exact value: -9429000 USD 2003-01-01 – 2003-12-31: -9429000 USD Inspect Net Income Open source Share or cite Citation for Net Income · METABASIS THERAPEUTICS INC · 2003-12-31 METABASIS THERAPEUTICS INC (edgar:1053221) Net Income: -9429000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T14:04:06Z Snapshot: 1d6c83a218ae99f29dc50d398c406edd10c3eadb1779cb3c6dd71ffe2d8d9366 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053221/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9429000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001104659-06-018931.txt#16989 The citation records this snapshot. The page link may show a newer release later.	−USD 15.73 million Exact value Exact value: -15729000 USD 2003-01-01 – 2003-12-31: -15729000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · METABASIS THERAPEUTICS INC · 2003-12-31 METABASIS THERAPEUTICS INC (edgar:1053221) Operating Cash Flow: -15729000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T14:04:06Z Snapshot: 1d6c83a218ae99f29dc50d398c406edd10c3eadb1779cb3c6dd71ffe2d8d9366 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053221/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15729000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001104659-06-018931.txt#17392 The citation records this snapshot. The page link may show a newer release later.	USD 898,000 Exact value Exact value: 898000 USD 2003-01-01 – 2003-12-31: 898000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · METABASIS THERAPEUTICS INC · 2003-12-31 METABASIS THERAPEUTICS INC (edgar:1053221) Capital Expenditure: 898000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T14:04:06Z Snapshot: 1d6c83a218ae99f29dc50d398c406edd10c3eadb1779cb3c6dd71ffe2d8d9366 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053221/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 898000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001104659-06-018931.txt#17497 The citation records this snapshot. The page link may show a newer release later.	−USD 16.63 million Calculation and evidence -15729000 − 898000 USD Exact free cash flow: -16627000 USD 2003-01-01 – 2003-12-31: -15729000 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 898000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · METABASIS THERAPEUTICS INC · 2003-12-31 METABASIS THERAPEUTICS INC (edgar:1053221) Free cash flow: -16627000 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T14:04:06Z Snapshot: 1d6c83a218ae99f29dc50d398c406edd10c3eadb1779cb3c6dd71ffe2d8d9366 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053221?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15729000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001104659-06-018931.txt#17392 Input fundies:CapitalExpenditure: 898000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001104659-06-018931.txt#17497 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 14.97 million Exact value Exact value: -14972000 USD 2004-01-01 – 2004-12-31: -14972000 USD Inspect Net Income Open source Share or cite Citation for Net Income · METABASIS THERAPEUTICS INC · 2004-12-31 METABASIS THERAPEUTICS INC (edgar:1053221) Net Income: -14972000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T14:04:06Z Snapshot: 1d6c83a218ae99f29dc50d398c406edd10c3eadb1779cb3c6dd71ffe2d8d9366 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053221/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14972000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001104659-07-018419.txt#16505 The citation records this snapshot. The page link may show a newer release later.	−USD 12 million Exact value Exact value: -11998000 USD 2004-01-01 – 2004-12-31: -11998000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · METABASIS THERAPEUTICS INC · 2004-12-31 METABASIS THERAPEUTICS INC (edgar:1053221) Operating Cash Flow: -11998000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T14:04:06Z Snapshot: 1d6c83a218ae99f29dc50d398c406edd10c3eadb1779cb3c6dd71ffe2d8d9366 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053221/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11998000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001104659-07-018419.txt#16937 The citation records this snapshot. The page link may show a newer release later.	USD 1.33 million Exact value Exact value: 1326000 USD 2004-01-01 – 2004-12-31: 1326000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · METABASIS THERAPEUTICS INC · 2004-12-31 METABASIS THERAPEUTICS INC (edgar:1053221) Capital Expenditure: 1326000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T14:04:06Z Snapshot: 1d6c83a218ae99f29dc50d398c406edd10c3eadb1779cb3c6dd71ffe2d8d9366 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053221/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1326000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001104659-07-018419.txt#17044 The citation records this snapshot. The page link may show a newer release later.	−USD 13.32 million Calculation and evidence -11998000 − 1326000 USD Exact free cash flow: -13324000 USD 2004-01-01 – 2004-12-31: -11998000 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 1326000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · METABASIS THERAPEUTICS INC · 2004-12-31 METABASIS THERAPEUTICS INC (edgar:1053221) Free cash flow: -13324000 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T14:04:06Z Snapshot: 1d6c83a218ae99f29dc50d398c406edd10c3eadb1779cb3c6dd71ffe2d8d9366 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053221?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11998000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001104659-07-018419.txt#16937 Input fundies:CapitalExpenditure: 1326000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001104659-07-018419.txt#17044 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 23.58 million Exact value Exact value: -23580000 USD 2005-01-01 – 2005-12-31: -23580000 USD Inspect Net Income Open source Share or cite Citation for Net Income · METABASIS THERAPEUTICS INC · 2005-12-31 METABASIS THERAPEUTICS INC (edgar:1053221) Net Income: -23580000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T14:04:06Z Snapshot: 1d6c83a218ae99f29dc50d398c406edd10c3eadb1779cb3c6dd71ffe2d8d9366 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053221/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -23580000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001047469-08-002925.txt#8137 The citation records this snapshot. The page link may show a newer release later.	−USD 13.51 million Exact value Exact value: -13513000 USD 2005-01-01 – 2005-12-31: -13513000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · METABASIS THERAPEUTICS INC · 2005-12-31 METABASIS THERAPEUTICS INC (edgar:1053221) Operating Cash Flow: -13513000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T14:04:06Z Snapshot: 1d6c83a218ae99f29dc50d398c406edd10c3eadb1779cb3c6dd71ffe2d8d9366 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053221/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13513000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001047469-08-002925.txt#8347 The citation records this snapshot. The page link may show a newer release later.	USD 3.22 million Exact value Exact value: 3220000 USD 2005-01-01 – 2005-12-31: 3220000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · METABASIS THERAPEUTICS INC · 2005-12-31 METABASIS THERAPEUTICS INC (edgar:1053221) Capital Expenditure: 3220000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T14:04:06Z Snapshot: 1d6c83a218ae99f29dc50d398c406edd10c3eadb1779cb3c6dd71ffe2d8d9366 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053221/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3220000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001047469-08-002925.txt#8399 The citation records this snapshot. The page link may show a newer release later.	−USD 16.73 million Calculation and evidence -13513000 − 3220000 USD Exact free cash flow: -16733000 USD 2005-01-01 – 2005-12-31: -13513000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 3220000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · METABASIS THERAPEUTICS INC · 2005-12-31 METABASIS THERAPEUTICS INC (edgar:1053221) Free cash flow: -16733000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T14:04:06Z Snapshot: 1d6c83a218ae99f29dc50d398c406edd10c3eadb1779cb3c6dd71ffe2d8d9366 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053221?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13513000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001047469-08-002925.txt#8347 Input fundies:CapitalExpenditure: 3220000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001047469-08-002925.txt#8399 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 33.27 million Exact value Exact value: -33268000 USD 2006-01-01 – 2006-12-31: -33268000 USD Inspect Net Income Open source Share or cite Citation for Net Income · METABASIS THERAPEUTICS INC · 2006-12-31 METABASIS THERAPEUTICS INC (edgar:1053221) Net Income: -33268000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T14:04:06Z Snapshot: 1d6c83a218ae99f29dc50d398c406edd10c3eadb1779cb3c6dd71ffe2d8d9366 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053221/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -33268000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001193125-09-069381.txt#7727 The citation records this snapshot. The page link may show a newer release later.	−USD 27.34 million Exact value Exact value: -27336000 USD 2006-01-01 – 2006-12-31: -27336000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · METABASIS THERAPEUTICS INC · 2006-12-31 METABASIS THERAPEUTICS INC (edgar:1053221) Operating Cash Flow: -27336000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T14:04:06Z Snapshot: 1d6c83a218ae99f29dc50d398c406edd10c3eadb1779cb3c6dd71ffe2d8d9366 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053221/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -27336000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001193125-09-069381.txt#7923 The citation records this snapshot. The page link may show a newer release later.	USD 3.23 million Exact value Exact value: 3230000 USD 2006-01-01 – 2006-12-31: 3230000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · METABASIS THERAPEUTICS INC · 2006-12-31 METABASIS THERAPEUTICS INC (edgar:1053221) Capital Expenditure: 3230000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T14:04:06Z Snapshot: 1d6c83a218ae99f29dc50d398c406edd10c3eadb1779cb3c6dd71ffe2d8d9366 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053221/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3230000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001193125-09-069381.txt#7984 The citation records this snapshot. The page link may show a newer release later.	−USD 30.57 million Calculation and evidence -27336000 − 3230000 USD Exact free cash flow: -30566000 USD 2006-01-01 – 2006-12-31: -27336000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 3230000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · METABASIS THERAPEUTICS INC · 2006-12-31 METABASIS THERAPEUTICS INC (edgar:1053221) Free cash flow: -30566000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T14:04:06Z Snapshot: 1d6c83a218ae99f29dc50d398c406edd10c3eadb1779cb3c6dd71ffe2d8d9366 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053221?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -27336000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001193125-09-069381.txt#7923 Input fundies:CapitalExpenditure: 3230000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001193125-09-069381.txt#7984 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 41.8 million Exact value Exact value: -41799000 USD 2007-01-01 – 2007-12-31: -41799000 USD Inspect Net Income Open source Share or cite Citation for Net Income · METABASIS THERAPEUTICS INC · 2007-12-31 METABASIS THERAPEUTICS INC (edgar:1053221) Net Income: -41799000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T14:04:06Z Snapshot: 1d6c83a218ae99f29dc50d398c406edd10c3eadb1779cb3c6dd71ffe2d8d9366 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053221/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -41799000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001193125-09-069381.txt#7727 The citation records this snapshot. The page link may show a newer release later.	−USD 36.38 million Exact value Exact value: -36383000 USD 2007-01-01 – 2007-12-31: -36383000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · METABASIS THERAPEUTICS INC · 2007-12-31 METABASIS THERAPEUTICS INC (edgar:1053221) Operating Cash Flow: -36383000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T14:04:06Z Snapshot: 1d6c83a218ae99f29dc50d398c406edd10c3eadb1779cb3c6dd71ffe2d8d9366 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053221/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -36383000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001193125-09-069381.txt#7923 The citation records this snapshot. The page link may show a newer release later.	USD 2.27 million Exact value Exact value: 2274000 USD 2007-01-01 – 2007-12-31: 2274000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · METABASIS THERAPEUTICS INC · 2007-12-31 METABASIS THERAPEUTICS INC (edgar:1053221) Capital Expenditure: 2274000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T14:04:06Z Snapshot: 1d6c83a218ae99f29dc50d398c406edd10c3eadb1779cb3c6dd71ffe2d8d9366 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053221/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2274000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001193125-09-069381.txt#7984 The citation records this snapshot. The page link may show a newer release later.	−USD 38.66 million Calculation and evidence -36383000 − 2274000 USD Exact free cash flow: -38657000 USD 2007-01-01 – 2007-12-31: -36383000 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 2274000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · METABASIS THERAPEUTICS INC · 2007-12-31 METABASIS THERAPEUTICS INC (edgar:1053221) Free cash flow: -38657000 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T14:04:06Z Snapshot: 1d6c83a218ae99f29dc50d398c406edd10c3eadb1779cb3c6dd71ffe2d8d9366 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053221?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -36383000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001193125-09-069381.txt#7923 Input fundies:CapitalExpenditure: 2274000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001193125-09-069381.txt#7984 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	−USD 42.31 million Exact value Exact value: -42314000 USD 2008-01-01 – 2008-12-31: -42314000 USD Inspect Net Income Open source Share or cite Citation for Net Income · METABASIS THERAPEUTICS INC · 2008-12-31 METABASIS THERAPEUTICS INC (edgar:1053221) Net Income: -42314000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T14:04:06Z Snapshot: 1d6c83a218ae99f29dc50d398c406edd10c3eadb1779cb3c6dd71ffe2d8d9366 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053221/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -42314000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001193125-09-069381.txt#7727 The citation records this snapshot. The page link may show a newer release later.	−USD 33.07 million Exact value Exact value: -33073000 USD 2008-01-01 – 2008-12-31: -33073000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · METABASIS THERAPEUTICS INC · 2008-12-31 METABASIS THERAPEUTICS INC (edgar:1053221) Operating Cash Flow: -33073000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T14:04:06Z Snapshot: 1d6c83a218ae99f29dc50d398c406edd10c3eadb1779cb3c6dd71ffe2d8d9366 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053221/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -33073000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001193125-09-069381.txt#7923 The citation records this snapshot. The page link may show a newer release later.	USD 525,000 Exact value Exact value: 525000 USD 2008-01-01 – 2008-12-31: 525000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · METABASIS THERAPEUTICS INC · 2008-12-31 METABASIS THERAPEUTICS INC (edgar:1053221) Capital Expenditure: 525000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T14:04:06Z Snapshot: 1d6c83a218ae99f29dc50d398c406edd10c3eadb1779cb3c6dd71ffe2d8d9366 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053221/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 525000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001193125-09-069381.txt#7984 The citation records this snapshot. The page link may show a newer release later.	−USD 33.6 million Calculation and evidence -33073000 − 525000 USD Exact free cash flow: -33598000 USD 2008-01-01 – 2008-12-31: -33073000 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 525000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · METABASIS THERAPEUTICS INC · 2008-12-31 METABASIS THERAPEUTICS INC (edgar:1053221) Free cash flow: -33598000 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T14:04:06Z Snapshot: 1d6c83a218ae99f29dc50d398c406edd10c3eadb1779cb3c6dd71ffe2d8d9366 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053221?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -33073000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001193125-09-069381.txt#7923 Input fundies:CapitalExpenditure: 525000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053221/0001193125-09-069381.txt#7984 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

25 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001053221, 1053221, edgar:1053221

METABASIS THERAPEUTICS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2008 2008-01-01 – 2008-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation